Lp(a)

Lp(a) Today & Tomorrow

S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know

What does your patient’s lipid panel actually tell you and what is it missing? In this special National Lipid Day…

Lp(a) Screening for Individuals at High ASCVD Risk

The Lipid Panel – Lipoprotein(a)

A Focused Update to the 2019 NLA Scientific Statement on Use of Lipoprotein(a) in Clinical Practice

The Lipid Panel – Lp(a) Today and Tomorrow

Case Study: Type 1 Diabetes, Familial Hypercholesterolemia, and Elevated Lipoprotein(a)

Familial hypercholesterolemia (FH) and type 1 diabetes (T1D) are characterized by significant morbidity and premature mortality. Lipoprotein(a) [Lp(a)], an independent…

Practical Pearls – Lipoprotein(a) in Focus: Current Knowledge & Approach to Patient Care

Practical Pearls – Promoting Lp(a) Awareness and Testing for Risk…

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group

Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice

Alan Brown, MD, FACC, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of “A Focused Update to the…

S5E3: What’s Next for Lipoprotein(a)? Insights from an Expert Discussion Group

Listen to Dr. Brown discuss with Dr. Koschinsky and Dr. Pena about how this important lipoprotein and potent cardiovascular risk…

Lipoprotein(a) Medications Under Development

Lipoprotein(a) (Lp(a)) resembles an LDL-like lipoprotein with apolipoprotein(a) covalently bound with a disulfide link to apolipoprotein B on the particle…

S6 Lipid Snippet | Universal Lipoprotein(a) Screening of Youth and Reverse Cascade Screening at a Primary Care Clinic

In this episode of Lipid Insights, Dr. Daniel Soffer interviews the Young Investigator abstract award winner during the 2025 Annual Scientific Sessions…

S6E10: Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease

Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed…

The ABCs of Lipoprotein(a)

In recent years, lipoprotein(a) [Lp(a)] has been recognized as a prevalent risk factor for cardiovascular disease. It is estimated that…

Aspirin Use and Lipoprotein(a) Genotypes in Primary Prevention

Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Although approximately 20% of the population has elevated…

Lipoprotein(a) and its Role in Cardiovascular Risk

Here we describe a case study of a 50- year-old physically active male wit h no significant past medical history…

Current Understanding of the Contribution of Lipoprotein(a) to Atherosclerotic Cardiovascular Disease Risk in Women

It is well-established that, compared to men, post-menopausal women enjoy a degree of protection against atherosclerotic cardiovascular disease (ASCVD).1  The…